Introduction {#s1}
============

Voltage-gated Ca^2+^ channels (VGCCs) are unique among voltage-gated ion channels because the permeant Ca^2+^ ion also acts as an intracellular second messenger, triggering diverse cellular functions ([@bib6]). VGCCs are therefore involved in neuronal and cardiac excitability as well as in muscle contraction, neurotransmitter release, hormone secretion and gene expression ([@bib6]; [@bib45]; [@bib12]; [@bib59]; [@bib66]). Consequently the modulation of VGCC activity plays a pivotal role in the regulation of cardiac and brain activities and this modulation is controlled by a variety of processes, including intracellular Ca^2+^ itself, which provides an important Ca^2+^-driven feedback control ([@bib25]; [@bib68]; [@bib54]; [@bib43]; [@bib30]; [@bib63]; [@bib51]; [@bib31]; [@bib66]).

VGCCs comprise three distinct subfamilies classified with respect to their biophysical and pharmacological (type), and molecular (Cav) entities: the L-type / Cav1, the N-, P/Q-, R-type / Cav2 and the T-type / Cav3 channels ([@bib26]). It was well demonstrated that both Cav1 and Cav2 channels are modulated by intracellular Ca^2+^ ([@bib43]; [@bib21]). For the Cav1 / L-type VGCCs, this Ca^2+^ feedback mechanism has been extensively studied in a wide spectrum of biological contexts and a rise in submembrane Ca^2+^ concentration induces complex effects depending on both the Ca^2+^ concentration and the duration of the Ca^2+^ entry ([@bib25]; [@bib68]; [@bib54]; [@bib43]; [@bib30]; [@bib63]; [@bib51]; [@bib31]). At the millisecond time scale, the Ca^2+^ entry via L-type channels induces a Ca^2+^-dependent inactivation (CDI) characterized by an acceleration of their inactivation kinetics ([@bib25]; [@bib68]; [@bib54]; [@bib43]; [@bib31]). For several seconds to a few minutes of stimulation, the cumulative Ca^2+^ entry induces a decrease of the L-type current amplitude, which is reversible if stimulation ceases for several minutes ([@bib25]; [@bib50], [@bib51]; [@bib31]). For longer period of stimulation, or activation of the ionotropic NMDA receptors, L-type channels are internalized, potentially degraded in lysosomes or recycled to the plasma membrane depending on the amount and the duration of the Ca^2+^ entry ([@bib30]; [@bib63]; [@bib31]). This precise Ca^2+^-dependent regulation of the L-type channel activity has a strong physiological role in avoiding cytotoxicity arising from Ca^2+^ overload ([@bib42]; [@bib6]; [@bib30]; [@bib63]; [@bib31]). Consequently, alteration of the Ca^2+^-dependent regulation of the L-type channels is deleterious and has important pathophysiological consequences as observed in the Timothy syndrome ([@bib60]; [@bib2]; [@bib8]; [@bib44]; [@bib22]).

Contrasting with this well-established Ca^2+^-dependent regulation of the L-type channels, it is presently unknown whether a change in intracellular Ca^2+^ concentration is involved in regulating T-type Ca^2+^ channel activity. The low-voltage-activated, T-type/Cav3 channels are specifically activated by small membrane depolarization below the threshold of classical sodium action potentials, producing a Ca^2+^ entry near the resting membrane potential and low-threshold Ca^2+^ spikes ([@bib34], [@bib35]; [@bib53]; [@bib67]). Importantly, availability of Cav3 channels is critically regulated by the resting membrane potential to control T-type channel activity. Because of the negative range of their steady-state inactivation (V~0.5~ near −70 mV), Cav3 channels are partially inactivated (reduced availability) in the range of the resting membrane potential of most neurons and a membrane hyperpolarization (usually triggered by inhibitory postsynaptic events) is needed to allow their recovery from inactivation (de-inactivation) and their subsequent opening ([@bib34]; [@bib53]; [@bib67]). This behavior is of particular importance in many types of neurons, in which Cav3 channels mediate rebound burst firing, especially in the thalamo-cortical circuit, where Cav3 channels control transition between awake and sleep states ([@bib34]; [@bib53]; [@bib5]; [@bib67]; [@bib62]). Overall, Cav3 channels are involved in the control of the Ca^2+^ homeostasis ([@bib13]; [@bib7]; [@bib53]), in Ca^2+^-dependent differentiation of neuronal, muscular and neuroendocrine cells ([@bib7]; [@bib46]; [@bib15]), as well as in Ca^2+^ overload toxicity in ischemia ([@bib49]; [@bib1]; [@bib29]). Importantly, an increase in the Cav3 channel activity has been implicated in several diseases including epilepsy, chronic pain, autism and primary aldosteronism ([@bib5]; [@bib67]). Although it is evident that a tight control of Cav3 channel activity is necessary to maintain Ca^2+^ homeostasis, there is no evidence yet that Cav3 channels are regulated by intracellular Ca^2+^ ions and/or by Ca^2+^ entry.

In this study, we have designed complementary electrophysiological experiments to explore whether the T-type/Cav3 channels are modulated by intracellular Ca^2+^ concentration. We document a feedback control mechanism that relies on Ca^2+^ entry via activated Cav3 channels or nearby Ca^2+^-permeable receptors. We provide evidence that dynamic changes and localized increase in the intracellular Ca^2+^ concentration at the vicinity Cav3 channels control availability of these channels, which underlies this novel regulation.

Results {#s2}
=======

Inhibition of the native T-type and the recombinant Cav3 currents by ionomycin {#s2-1}
------------------------------------------------------------------------------

In order to evaluate whether T-type channels would be regulated by a rise in intracellular Ca^2+^ (\[Ca^2+^\]~INT~), we first used the Ca^2+^ ionophore ionomycin. In D-hair mechanoreceptor sensory neurons, which specifically express a high density of T-type channels ([@bib58]; [@bib23]; [@bib64]), extracellular perfusion of 10 µM ionomycin induced a potent decrease of the T-type current ([Figure 1a](#fig1){ref-type="fig"}). This current inhibition (\~85% in average) occurred in the minute range ([Figure 1b](#fig1){ref-type="fig"}) and was associated with a large hyperpolarizing shift in the steady-state inactivation curve (\~22 mV, p*\<*0.001, [Figure 1c](#fig1){ref-type="fig"}). Similar findings were obtained with the three cloned Cav3 channels transiently expressed in tsA-201 cells. Ionomycin potently inhibited the Cav3.1, Cav3.2 and Cav3.3 currents by about 80% ([Figure 1d](#fig1){ref-type="fig"}). This effect was combined with an acceleration of the inactivation kinetics (\~3 times, [Figure 1e](#fig1){ref-type="fig"}) and a hyperpolarizing shift in the steady-state inactivation curve (\~23 mV, p*\<*0.001, [Figure 1f](#fig1){ref-type="fig"}).10.7554/eLife.22331.003Figure 1.Ionomycin induces inhibition of neuronal T-type and recombinant Cav3 currents.(**a**--**c**) Extracellular application of ionomycin induces inhibition of the native T-type current in D-hair sensory neurons. (**a**) Effect of 10 µM ionomycin (iono) on the T-type current recorded from a D-hair sensory neuron. (**b**) Time course and average effect (inset) of ionomycin (n = 5). (**c**) Steady-state inactivation of the native T-type current before (ctrl) and after ionomycin application (n = 5). (**d**--**f**) Ionomycin induces inhibition of the recombinant Cav3.1, Cav3.2 and Cav3.3 currents. (**d**) Effect of ionomycin application (10 µM) on the Cav3.3 current amplitude. Average effect of ionomycin on Cav3.1, Cav3.2 and Cav3.3 currents (inset, n = 6--7 per bar). (**e**) Inactivation kinetics of the Cav3 currents in the absence and in the presence of ionomycin (n = 6--7 per bar). (**f**) Steady-state inactivation of Cav3.1, Cav3.2 and Cav3.3 currents before and after ionomycin application (n = 6--7). In (**a**), (**b**), (**d**) and (**e**), the currents were recorded at −30 mV from a holding potential (HP) of −80 mV. In (**c**) and (**f**), the currents were elicited at −30 mV from HPs ranged from −130 to −40 mV (5 s duration) and the data were fitted with the Boltzmann equation.**DOI:** [http://dx.doi.org/10.7554/eLife.22331.003](10.7554/eLife.22331.003)

Inhibition of Cav3.3 current at high frequency of stimulation is caused by the Ca^2+^entry {#s2-2}
------------------------------------------------------------------------------------------

Considering that recombinant Cav3 channels, especially Cav3.3 channels, can generate large entry of Ca^2+^ during fast stimulation protocols ([@bib35]; [@bib40]; [@bib14]; [@bib53]), we have investigated whether these channels might be modulated by their own activity. Cav3 currents were recorded in the presence of 2 mM extracellular Ca^2+^ using fast test-pulse (TP) stimulation (1 Hz), which allows a cumulative Ca^2+^ entry. Experiments were performed after dialyzing the cell with 10 mM EGTA, which delimits the change in Ca^2+^ concentration only at the vicinity of the channel ([@bib47]; [@bib55]; [@bib19]). The Cav3.3 current amplitude recorded using fast TP stimulation (1 Hz) progressively decreased to \~50% of the control value ([Figure 2a](#fig2){ref-type="fig"}). In average, the current decrease was maximal and stable after \~40 s with an average half-time of 18 s ([Figure 2a and f](#fig2){ref-type="fig"}). The current decrease was also associated with a marked acceleration of the inactivation kinetics ([Figure 2a](#fig2){ref-type="fig"}), \~3 times after 40 s stimulation ([Figure 2e](#fig2){ref-type="fig"}). This effect was fully reversible and activity-dependent since the stopping of the TP stimulation for only 5 s already induced \~30% recovery of the current. Recovery was complete after \~2 min without TP stimulation with an average half-time of 20 s ([Figure 2f](#fig2){ref-type="fig"}).10.7554/eLife.22331.004Figure 2.Ca^2+^ induces a time-dependent inhibition of the Cav3.3 current at high frequency of stimulation.(**a**) Typical examples of Cav3.3 currents elicited using a 1 Hz test pulse (TP) stimulation of −30 mV (450 ms duration) from a HP of −100 mV. The traces obtained at the beginning of the stimulation (1 s) and after 40 s stimulation are indicated in blue and red, respectively. (**b**--**d**) Similar experiments for a TP of +100 mV (**b**), in the absence extracellular Ca^2+^ (**c**, TP −30 mV) and in the presence of intracellular BAPTA (**d**, TP −30 mV). (**e**) Inactivation kinetics of the Cav3.3 current measured at the beginning (1 s, blue bars) and after 40 s stimulation (red bars, n = 15--28 per bar). (**f**) Time-course of the Cav3.3 current inhibition during 1 Hz stimulation and time-course of the recovery of the Cav3.3 current as a function of time after stimulation (n = 13--28 per point). The half-time of both inhibition and recovery of the Cav3.3 current are indicated in green. (**g**) Summary of the data obtained on the three Cav3 currents at different frequencies of TP stimulation (n = 5--40 per bar).**DOI:** [http://dx.doi.org/10.7554/eLife.22331.004](10.7554/eLife.22331.004)10.7554/eLife.22331.005Figure 2---figure supplement 1.The effect of free Ca^2+^ application on the Cav3.3 current recorded in cell-free inside-out patches.(**a**) Effect of 10 µM and 100 µM Ca^2+^-containing solution on the Cav3.3 current recorded during voltage-ramp protocols in the inside-out patch configuration. (**b**) Time course of the Cav3.3 current during the experiment presented in (**a**). (**c**) Scatter plot and average effect of 1 µM, 10 µM and 100 µM Ca^2+^-containing solution (n = 10--19 per bar).**DOI:** [http://dx.doi.org/10.7554/eLife.22331.005](10.7554/eLife.22331.005)10.7554/eLife.22331.006Figure 2---figure supplement 2.Inhibition of the Cav3.1 current at a high frequency of TP stimulation but not of the Cav3.2 current.Typical examples of Cav3.1 and Cav3.2 currents elicited by a TP stimulation at a frequency of 1 Hz (TP of −30 mV, 180 ms duration) from a HP of −100 mV. (**a**) Cav3.1 current recorded at the beginning of the stimulation (1 s) and after 80 s stimulation (80 s). (**b**) Time-course of the Cav3.1 current inhibition during this 1 Hz stimulation protocol (n = 40). (**c**) Inactivation kinetics of the Cav3.1 current measured at the beginning (1 s) and after 80 s of stimulation (n = 40). (**d**) Cav3.2 current recorded at the beginning of the stimulation (1 s) and after 80 s stimulation. (**e**) Time-course of the Cav3.2 current during a 1 Hz stimulation protocol (n = 23). (**f**) Inactivation kinetics of the Cav3.2 current measured at the beginning (1 s) and after 80 s stimulation (n = 23).**DOI:** [http://dx.doi.org/10.7554/eLife.22331.006](10.7554/eLife.22331.006)

In contrast with the data obtained for a TP at −30 mV ([Figure 2a](#fig2){ref-type="fig"}), the Cav3.3 current was unchanged when the TP was set at +100 mV (a membrane potential value above the reversal potential of Cav3 current, leading to an outward current, [Figure 2b](#fig2){ref-type="fig"}). These experiments clearly indicate that the decrease in current amplitude observed for a fast TP stimulation at −30 mV does not involve a voltage-dependent inactivation process that would occur at high frequency of stimulation, but is rather related to the Ca^2+^ entry via Cav3.3 channels. Also, in the absence of extracellular Ca^2+^, the sodium inward current through Cav3.3 channels remained unchanged during the time of the fast TP protocol at −30 mV ([Figure 2c](#fig2){ref-type="fig"}). In addition, no change in Cav3.3 current properties were obtained in the presence of 2 mM extracellular Ca^2^ when cells were dialyzed with an intracellular medium containing BAPTA instead of EGTA ([Figure 2d and e](#fig2){ref-type="fig"}). This difference in susceptibility to BAPTA and EGTA is characteristic of a process driven by a localized rise in submembrane Ca^2+^, without the need for a global Ca^2+^ increase ([@bib47]; [@bib55]; [@bib19]).

We further investigated whether Ca^2+^ ions could affect the Cav3.3 current in cell-free inside-out patches ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Cav3.3 currents were recorded by voltage-ramps in the presence of 100 mM external Ba^2+^ whereas Ca^2+^-containing solutions were applied to the internal side of the membrane in the inside-out patch configuration ([Figure 2---figure supplement 1a](#fig2s1){ref-type="fig"}). Because of the surface charge effect due to the use of 100 mM Ba^2+^, voltage ramps were applied from a HP −50 mV to match whole-cell experiments (see also [Figure 4](#fig4){ref-type="fig"}). In this configuration, the application of 1, 10 or 100 µM Ca^2+^ during more than 60 s ([Figure 2---figure supplement 1b](#fig2s1){ref-type="fig"}) did not induce a significant inhibition of the Cav3.3 current as compared to a control solution containing 1 mM EGTA/0 mM Ca^2+^ ([Figure 2---figure supplement 1c](#fig2s1){ref-type="fig"}), suggesting that Ca^2+^-induced Cav3.3 inhibition requires some additional components preserved in the whole-cell configuration. However, our data do not exclude a possible direct effect of Ca^2+^ ions at higher (mM) concentrations.

The decrease in Cav3.3 current gradually developed with the increase in TP frequency. While no decrease was observed at low frequency of TP (0.033 Hz), the decrease in Cav3.3 current became significant at 0.2 Hz and further increased at 0.5 and 1 Hz ([Figure 2g](#fig2){ref-type="fig"}). Similar experiments were conducted with the Cav3.1 and Cav3.2 T-type channels. The amplitude of Cav3.1 current decreased modestly and only at the TP frequency of 1 Hz ([Figure 2g](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2a--b](#fig2s2){ref-type="fig"}). Contrasting with the results described above, the Cav3.2 current showed no inhibition but rather a small increase in amplitude at fast stimulation ([Figure 2g](#fig2){ref-type="fig"} and [Figure 2---figure supplement 2d--e](#fig2s2){ref-type="fig"}). For Cav3.1 channels, the decrease in current amplitude was associated with faster inactivation kinetics ([Figure 2---figure supplement 2c](#fig2s2){ref-type="fig"}), while inactivation kinetics of the Cav3.2 current was unchanged ([Figure 2---figure supplement 2f](#fig2s2){ref-type="fig"}). Similar to that described for the Cav3.3 current, Cav3.1 current amplitude and inactivation kinetics were unchanged after dialyzing the cells with BAPTA ([Figure 2g](#fig2){ref-type="fig"}).

Ca^2+^ entry during fast TP stimulation induces a negative shift in the steady-state inactivation {#s2-3}
-------------------------------------------------------------------------------------------------

We next investigated the biophysical mechanism underlying the Cav3.3 current decrease. We first hypothesized that the recovery from inactivation of the Cav3.3 current might be affected during a fast stimulation protocol in a Ca^2+^-sensitive manner. A paired-pulse protocol with increasing inter-pulse durations (100, 400 or 1000 ms) was designed to analyze the kinetics of recovery from the first (Stim 1) to the fortieth (Stim 40) paired-pulse stimulation, as exemplified for an inter-pulse duration of 100 ms in [Figure 3a](#fig3){ref-type="fig"}. These experiments revealed that the recovery kinetics of the Cav3.3 current was unaffected at the three inter-pulse durations tested ([Figure 3b](#fig3){ref-type="fig"}). In contrast, we found that the steady-state inactivation of Cav3.3 current was strongly modified using fast stimulation protocols. This was evidenced using a paired-pulse protocol with variable inter-pulse potentials ranging from −40 to −110 mV (as exemplified for an inter-pulse potential of −70 mV in [Figure 3c](#fig3){ref-type="fig"}). This fast stimulation protocol produced a \~10 mV hyperpolarizing shift in the *V*~0.5~ value of the steady-state inactivation curve (from −72.4 mV for Stim 1 to −81.1 mV for the Stim 40, p*\<*0.001), without any change in the slope of the inactivation curve ([Figure 3d](#fig3){ref-type="fig"}). Importantly, this effect was lost in the presence of intracellular BAPTA ([Figure 3d](#fig3){ref-type="fig"}). In addition, we found that the fast stimulation of Cav3.3 current also induced a small but significant leftward shift in the steady-state activation (from −52.6 to −55.9 mV, p*\<*0.01) as well as an increase in the slope of the activation curve (from 4.7 to 5.6 mV, p*\<*0.05, [Figure 3e--f](#fig3){ref-type="fig"}).10.7554/eLife.22331.007Figure 3.High frequency stimulation induces a Ca^2+^-dependent negative shift in the Cav3.3 steady-state inactivation properties.(**a**--**b**) Recovery from short-term inactivation of the Cav3.3 current measured by a paired-pulse stimulation (inter-stimulation 1 s) applied 40 times (Stim. 1 to Stim. 40). The interval between the first pulse (P1) and the second pulse (P2), i.e. interpulse, is 100, 400 or 1000 ms, as presented in (**a**) for an interpulse interval of 100 ms. The recovery from short-term inactivation (P2/P1), as a function of the interpulse duration is quantified for the first stimulation (Stim. 1) and the 40th stimulation (Stim. 40) (**b**, n = 5--7 per point). (**c**--**d**) Steady-state inactivation of the Cav3.3 current measured using a paired-pulse stimulation applied 40 times. The Vm between the two pulses ranged from −110 to −40 mV, as illustrated in (**c**) for a Vm of −70 mV. Steady-state inactivation (measured at P2) as a function of the Vm is determined for the first stimulation (Stim. 1) and for the 40th stimulation (Stim. 40) (**d**, n = 5--9 per point). (**e**--**f**) Current-voltage (I--V) protocol (**e**) and activation curve (**f**) of the Cav3.3 current during 1 Hz or 0.05 Hz stimulation. The Cav3.3 current was stimulated at 1 Hz or 0.05 Hz until reaching the steady-state just before I-V protocols, which were performed by a double-pulse protocol to maintain the 1 Hz stimulation effect (n = 17).**DOI:** [http://dx.doi.org/10.7554/eLife.22331.007](10.7554/eLife.22331.007)10.7554/eLife.22331.008Figure 3---figure supplement 1.Paired-pulse stimulation at high frequency induces a negative shift in the Cav3.1 steady-state inactivation properties.(**a**--**b**) Steady-state inactivation of the Cav3.1 current measured using a paired-pulse stimulation (inter-stimulation 1 s) applied 80 times (Stim 1 to Stim 80). The membrane potential (Vm) between the two pulses ranged from −110 to −50 mV, as illustrated in (**a**) for a Vm of −70 mV. Steady-state inactivation (measured at P2) as a function of the Vm is determined for the first stimulation (Stim 1) and for the 80th stimulation (Stim 80, (**b**), n = 5--13 per point). (**c**) Recovery from short-term inactivation of the Cav3.1 current measured by a paired-pulse stimulation (inter-stimulation 1 s) applied 80 times (Stim 1 to Stim 80). The recovery from short-term inactivation, as a function of the interpulse duration (100, 400 or 1000 ms) is quantified for the first stimulation (Stim 1) and for the 80th stimulation (n = 8--9 per point). (**d**) Activation curve of the Cav3.1 current measured during 1 Hz or 0.05 Hz stimulation. The Cav3.1 current was stimulated at 1 Hz or 0.05 Hz until reaching the steady-state just before I-V protocols, which were performed by a double-pulse protocol to maintain the 1 Hz stimulation effect (n = 6).**DOI:** [http://dx.doi.org/10.7554/eLife.22331.008](10.7554/eLife.22331.008)10.7554/eLife.22331.009Figure 4.Inhibition of Cav3.3 current as a function of the HP.(**a**) Simulation of the Cav3.3 current at −30 mV from an HP of −70 mV. The Cav3.3 current was modeled from experiments presented in [Figure 3](#fig3){ref-type="fig"}. The blue trace corresponds to the Cav3.3 current properties obtained before the 1 Hz stimulation whereas the red trace corresponds to the Cav3.3 current properties obtained after 40 s stimulation at 1 Hz. (**b**) Cav3.3 current elicited at a frequency of 0.2 Hz from a HP of −110 mV (left panel) and a HP of −80 mV (right panel). (**c**) Inhibition of Cav3.3 current after 150 s stimulation as a function of the HP (n = 5--8 per point).**DOI:** [http://dx.doi.org/10.7554/eLife.22331.009](10.7554/eLife.22331.009)

Similar findings were obtained with Cav3.1 channels since these paired-pulse protocols revealed a \~5 mV hyperpolarizing shift of the steady-state inactivation curve (p*\<*0.001, [Figure 3---figure supplement 1a--b](#fig3s1){ref-type="fig"}) with no significant effect on the recovery kinetics ([Figure 3---figure supplement 1c](#fig3s1){ref-type="fig"}) and the steady-state activation curve of the Cav3.1 current ([Figure 3---figure supplement 1d](#fig3s1){ref-type="fig"}).

Ca^2+^-dependent inhibition of T-type channels is higher at physiological resting membrane potentials {#s2-4}
-----------------------------------------------------------------------------------------------------

These latter findings strongly suggest that the decrease in Cav3.3 current observed in fast stimulation protocols might be more important in the range of physiological resting membrane potentials \~−70 / −80 mV, for which Cav3.3 channels are partially inactivated. In order to test this possibility, the Cav3.3 current properties before and after fast stimulation were modeled using the Hodgkin-Huxley formalism as previously described for the native T-type current in thalamic neuron ([@bib33]; [@bib20]). We used the NEURON simulation environment ([@bib32]) as modified previously in order to perform voltage-clamp experiments ([@bib20]). In this simulation, the model indicated that the Cav3.3 current elicited from HP −70 mV would decrease \~75% ([Figure 4a](#fig4){ref-type="fig"}) according to the shift in the steady-state inactivation observed in [Figure 3d](#fig3){ref-type="fig"}. To validate experimentally these data, we performed voltage-clamp experiments at different HPs. Using 0.2 Hz frequency of TP stimulation (to allow current recovery at more depolarized HPs), the decrease in Cav3.3 current was below 20% at HP −110 mV whereas the current decrease was more prominent (\~40%, p*\<*0.01) at HP −80 mV ([Figure 4b](#fig4){ref-type="fig"}). Interestingly, the decrease in Cav3.3 current was also reduced at HPs above −70 mV and was less than 10% at HP −55 mV ([Figure 4c](#fig4){ref-type="fig"}). This U-shaped relationship ([Figure 4c](#fig4){ref-type="fig"}) could be explained by two interlinked mechanisms: (i) at negative membrane potentials (below −90 mV) the shift in the steady-state inactivation curve has little impact on the decrease in current amplitude (see [Figure 3d](#fig3){ref-type="fig"}); (ii) the small decrease observed at HPs above −70 mV would be related to the reduced Ca^2+^ entry at depolarized membrane potentials.

To directly test this latter hypothesis, the Cav3.3 current was recorded using fast TP stimulation (1 Hz) at HP −100 mV and then immediately at HP −70 mV ([Figure 5a](#fig5){ref-type="fig"}). At HP −100 mV during 40 s, the fast TP stimulation induced a large Ca^2+^ entry as evidenced by the decrease in Cav3.3 current amplitude ([Figure 5b](#fig5){ref-type="fig"}, left panel). Then, when the HP was immediately switched to −70 mV ([Figure 5b](#fig5){ref-type="fig"}, right panel), we observed a significant increase in the current amplitude, i.e. recovery, that reached a steady-state after \~100 s ([Figure 5b](#fig5){ref-type="fig"}). The Cav3.3 current increased furthermore after the stopping of the simulation for 2 min ([Figure 5b](#fig5){ref-type="fig"}). The average current amplitude increase during these experiments was \~400% when using a 0.2 Hz TP stimulation, and up to 600% at 1 Hz ([Figure 5d](#fig5){ref-type="fig"}). Similarly, large effects on the Cav3.1 current were also found in these experiments ([Figure 5c](#fig5){ref-type="fig"}). Whereas the Cav3.1 current decreased only modestly at HP −100 mV (\~10%, see also [Figure 2g](#fig2){ref-type="fig"}), the increase in the Cav3.1 current following the switch to HP −70 mV reached \~600% ([Figure 5c and d](#fig5){ref-type="fig"}) as described for the Cav3.3 current. This strong recovery of Cav3.3 and Cav3.1 currents at depolarized HPs clearly indicate that the shift in the steady-state inactivation is a dynamic and reversible mechanism. Importantly, no increase in Cav3.3 and Cav3.1 current was obtained in cells dialyzed with BAPTA ([Figure 5d](#fig5){ref-type="fig"}), further confirming a local Ca^2+^-dependent feedback mechanism.10.7554/eLife.22331.010Figure 5.Potent T-type current recovery at physiological resting potentials.(**a**--**c**) Fast TP stimulation (TP −30 mV) using HP of −100 mV to induce inhibition, switched to a HP of −70 mV to induce recovery (see protocol in (**a**)). The inhibition of Cav3.3 and Cav3.1 currents was measured using fast TP stimulation at a HP of −100 mV (**b**--**c**, left panels) whereas the recovery of the Cav3.3 and Cav3.1 currents was measured on a HP of −70 mV (**b**--**c**, right panels). (**d**) Quantification of the increase (recovery) in Cav3.3, Cav3.1 and Cav3.2 currents (at HP −70 mV) as a function of the TP stimulation frequency (n = 5--40 per bar). The normalized current corresponds to the ratio of the current obtained after 2 min without stimulation (blue trace) to the initial current (1 s, red trace) recorded at a HP −70 mV.**DOI:** [http://dx.doi.org/10.7554/eLife.22331.010](10.7554/eLife.22331.010)10.7554/eLife.22331.011Figure 5---figure supplement 1.Modulation of the Cav3.2 Met1549Ile mutant channel at a high frequency of stimulation.Similar to that described for [Figure 5](#fig5){ref-type="fig"}, the Cav3.2 current recovery was measured at a HP of −80 mV (**a**--**b**, right panels) after their inhibition by 1 Hz stimulation at a HP of −100 mV (a-b, left panels) for wild-type (WT) Cav3.2 channels (**b**) and for the Cav3.2 Met1549Ile channels (**c**). The average current decrease at HP −100 mV and the average current increase at HP −80 mV are shown in (**c**) as insets in the left and the right panels, respectively (n = 23--31).**DOI:** [http://dx.doi.org/10.7554/eLife.22331.011](10.7554/eLife.22331.011)

Interestingly, we did not observe any variation in the Cav3.2 current in these experiments ([Figure 5d](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1b](#fig5s1){ref-type="fig"}). This finding suggests that because of its biophysical properties, i.e. rapid inactivation kinetics (as compared to Cav3.3) and its slow recovery from inactivation (as compared to Cav3.1 and Cav3.3) ([@bib39]; [@bib40]; [@bib56]; [@bib14]; [@bib53]), the Cav3.2 current generated in fast TP stimulation does not allow sufficient Ca^2+^ entry to induce the Ca^2+^-dependent regulation observed for Cav3.1 and Cav3.3 channels. To directly test this hypothesis, we have studied a Cav3.2 gain of function mutant at Met1549, recently identified in patients with hypertension due to primary aldosteronism ([@bib57]; [@bib18]). The Met1549Ile Cav3.2 mutant presents slower inactivation and deactivation kinetics and is expected to induce much larger Ca^2+^ entry than the wild-type channel ([@bib18]). We found that the Met1549Ile Cav3.2 current decreased by \~15% during 1 Hz stimulation at HP −100 mV, whereas the current progressively increased when switched at HP −80 mV to reach a \~300% increase ([Figure 5---figure supplement 1c](#fig5s1){ref-type="fig"}). Altogether, these results demonstrate a common Ca^2+^-dependent modulation mechanism for the three Cav3 currents, which depends mainly on the amount of the Ca^2+^ entry and on Cav3 biophysical properties.

Ca^2+^-dependent inhibition of Cav3.3 current during action potential (AP) clamp stimulation {#s2-5}
--------------------------------------------------------------------------------------------

In order to investigate whether the Ca^2+^-dependent modulation of the T-type current occurred during more physiological paradigms, we recorded Cav3.3 current during a voltage-clamp protocol mimicking thalamic neuronal activities, which was previously described in details ([@bib14]). In these experiments, we found that the Cav3.3 current progressively increased during the first burst of spikes and then progressively decreased during the time course of the stimulation ([Figure 6a](#fig6){ref-type="fig"}). In addition, a 'rebound' in the Cav3.3 current was clearly associated with the depolarization after potential (DAP) transition, as previously described ([@bib14]). We estimated the current increase as the ratio of the Cav3.3 current obtained at the fourth spike to the first one ([Figure 6b](#fig6){ref-type="fig"}), whereas the decrease of the current was estimated as the ratio of the Cav3.3 current obtained at the thirteenth spike to the first one ([Figure 6c](#fig6){ref-type="fig"}). Interestingly, the Cav3.3 current increase was similar when cells were dialyzed with an intracellular medium containing either EGTA or BAPTA and reached in average \~300%, suggesting that the current increase is not dependent of intracellular Ca^2+^ (p*\>*0.05, [Figure 6b](#fig6){ref-type="fig"}). In contrast, the decrease in the Cav3.3 current was bigger in cells dialyzed with EGTA as compared to BAPTA-dialyzed cells (p*\<*0.001, [Figure 6c](#fig6){ref-type="fig"}). Importantly, these results were obtained during the first stimulation of the Cav3.3 current suggesting that the Ca^2+^-dependent modulation of the Cav3.3 current could have a strong neuronal impact. To further investigate the behavior of the Cav3.3 current during AP clamp experiments, we performed this stimulation several times at a frequency of 1 Hz whereas the cells were clamped at HP −100 mV between each stimulation to allow Cav3.3 current recovery ([Figure 6a](#fig6){ref-type="fig"}). We found that the Cav3.3 current recorded during an AP as well as the 'rebound' in the Cav3.3 current associated with the DAP progressively decreased when the protocol was repeated 40 times in cells dialyzed with EGTA ([Figure 1a](#fig1){ref-type="fig"}). To account for the total Cav3.3 current variation, we calculated the integral of the Cav3.3 current at each stimulation ([Figure 6d](#fig6){ref-type="fig"}). This analysis revealed that the total Cav3.3 current decrease was \~80% in cells dialyzed with EGTA whereas the current decrease was less than 15% in cells dialyzed with BAPTA (p*\<*0.001, [Figure 6d](#fig6){ref-type="fig"}), indicating further the robust Ca^2+^-dependent modulation of Cav3.3 current during AP-clamp stimulation.10.7554/eLife.22331.012Figure 6.Ca^2+^-dependent inhibition of the Cav3.3 current during action potential-clamp experiments.(**a**) The top trace represents a burst activity of a thalamic neuron which was used as a waveform. Typical Cav3.3 current recorded after dialyzing the cell with EGTA (middle panel) or with BAPTA (lower panel). (**b**) Average increase of the Cav3.3 current during the first spikes recorded at the first stimulation. The current increase is quantified as the ratio of the current recorded at the fourth to the first spike (n = 12--14). (**c**) Average decrease of the Cav3.3 current during the first stimulation quantified as the ratio of the thirteenth to the first spike (n = 12--14). (**d**) Time course of the total Cav3.3 current during 40 s stimulation. The total Cav3.3 current is quantified as the area under the curve (pA \* ms) (n = 12--14).**DOI:** [http://dx.doi.org/10.7554/eLife.22331.012](10.7554/eLife.22331.012)

Activation of Ca^2+^-permeable ionotropic receptors also induces Cav3 current decrease {#s2-6}
--------------------------------------------------------------------------------------

We next investigated whether activation of a Ca^2+^-permeable ionotropic receptor might also induce Cav3 current inhibition, including Cav3.2. In cells co-expressing the purinergic P2X4 receptor and Cav3.1, the Cav3.1 current was strongly decreased after extracellular perfusion of a solution containing the purinergic agonist ATP, which generated an inward current of several seconds ([Figure 7a](#fig7){ref-type="fig"}). Similar results were obtained for Cav3.2 and Cav3.3 currents, and ATP caused in average \~80% inhibition of the three Cav3 current ([Figure 7b](#fig7){ref-type="fig"}). The decrease in Cav3 current induced by P2X4 activation was coupled to an acceleration of the current inactivation kinetics ([Figure 7c](#fig7){ref-type="fig"}) and a negative shift in the steady-state inactivation ([Figure 7d](#fig7){ref-type="fig"}). Importantly, these effects were absent when similar experiments were performed in the absence of extracellular Ca^2+^ ([Figure 7b](#fig7){ref-type="fig"}). Because the current decrease could involve a change in the cell surface density of the channels, we have investigated whether the membrane expression of Cav3.3 channels would be modulated by P2X4 activation ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). To this end, we used a Cav3.3 channel construct containing an extracellular HA tag ([@bib3]), which allows the measure of its cell surface expression by enzyme-linked immunosorbent assay/luminometry ([Figure 7---figure supplement 1a](#fig7s1){ref-type="fig"}). We found that the ATP treatment did not induce significant change in membrane expression of Cav3.3-HA channels in cells co-transfected with either the P2X4 receptor or the pcDNA3 plasmid ([Figure 7---figure supplement 1b](#fig7s1){ref-type="fig"}), suggesting that the current decrease did not involve a change in the cell surface density of the channels. To extend these findings to other classes of physiologically relevant ionotropic receptors, electrophysiological experiments were performed with the Ca^2+^-permeable NMDA, 5-HT3, TRPA1 and TRPV1 receptors ([Figure 7e](#fig7){ref-type="fig"}). According to the results obtained with the P2X4 receptors, activation of all these receptors produced a 60% to 90% decrease of Cav3.1, Cav3.2 and Cav3.3 currents and this effect was only observed in the presence of extracellular Ca^2+^ (p*\<*0.001, [Figure 7e](#fig7){ref-type="fig"}). This set of experiments further demonstrate that Ca^2+^ entry into cells controls a Ca^2+^-dependent modulation of Cav3 availability.10.7554/eLife.22331.013Figure 7.Ca^2+^ entry via Ca^2+^-permeable ionotropic receptors inhibits Cav3 currents.(**a**) Effect of 10 µM ATP application on the Cav3.1 current recorded in a tsA-201 cell expressing the P2X4 receptor. The Cav3.1 current recorded just before (blue trace) and just after (red trace) the application of an ATP solution (black trace, P2X4 current). (**b**) Summary of ATP effect on the Cav3.1, the Cav3.2 and the Cav3.3 current recorded in tsA-201 cells expressing or not (pcDNA3) the P2X4 receptor in the presence or in the absence of 2 mM Ca^2+^ in the extracellular solution (n = 5--23 per bar). (**c**) Inactivation kinetics of the Cav3 currents in the absence and in the presence of ATP (2 mM Ca^2+^, n = 11--18 per bar). (**d**) Steady-state inactivation properties of the Cav3 currents the presence and in the absence of ATP (2 mM Ca^2+^, n = 10--17 per point). (**e**) Summary of the effect of NMDA, 5-HT3, TRPA1 and TRPV1 receptor activation on the Cav3 current amplitude recorded in the presence or in the absence of 2 mM Ca^2+^ in the extracellular saline (n = 5--30 per bar). In all these experiments the HP is −80 mV.**DOI:** [http://dx.doi.org/10.7554/eLife.22331.013](10.7554/eLife.22331.013)10.7554/eLife.22331.014Figure 7---figure supplement 1.Effect of P2X4 activation on membrane density of Cav3.3 channels.(**a**) Schematic representation of a Cav3.3 channel construct containing an extracellular HA tag (located in the IS5-pore loop) used to measure its membrane expression in tsA-201 cells. The cells were co-transfected with the Cav3.3 channel and either the P2X4 receptor or the pcDNA3 plasmid. (**b**) Quantification by ELISA/luminometry of the membrane expression levels of HA-tagged Cav3.3 channels after treatment with 10 µM ATP. The histogram represents relative light unit (RLU) normalized toward the values obtained in the control condition (P2X4 without ATP treatment).**DOI:** [http://dx.doi.org/10.7554/eLife.22331.014](10.7554/eLife.22331.014)

Discussion {#s3}
==========

This study reveals that T-type / Cav3 channels are dynamically regulated by changes in intracellular Ca^2+^ concentration. This novel regulation involves a Ca^2+^-dependent modulation of Cav3 availability. It was unraveled by demonstrating that a rise in submembrane Ca^2+^ at the vicinity of the Cav3 channels can cause a hyperpolarizing shift in the steady-state inactivation, leading to a strong Cav3 current decrease at physiological resting membrane potentials. This localized increase in intracellular Ca^2+^ can be generated by the Cav3 channel activity itself, especially for Cav3.3 channels, or by other routes of Ca^2+^ entry through the plasma membrane as obtained following activation of various Ca^2+^-permeable ionotropic receptors, all inducing a potent inhibition of Cav3.1, Cav3.2 and Cav3.3 currents. Importantly, all the effects described here were observed in 2 mM Ca^2+^-containing saline, which corresponds to the physiological range of extracellular Ca^2+^ concentration in native tissues ([@bib37]), and were lost in the presence of intracellular BAPTA.

The Ca^2+^-dependent modulation revealed here was best evidenced with Cav3.3, which allows the largest Ca^2+^ entry among Cav3 channel family ([@bib39]; [@bib40]; [@bib14]; [@bib53]). The decrease in Cav3.3 current amplitude was well correlated with the increase in the frequency of the TP stimulation. The reduction in Cav3.3 current amplitude was \~50% at 1 Hz frequency of stimulation and reached \~80% during neuronal activities in action potential clamp, suggesting that intracellular Ca^2+^ could be an important physiological regulator of Cav3 current. Importantly, this effect was very dynamic both in its induction (T~0.5~\~18 s) and in its recovery (T~0.5~\~20 s). Altogether, our results demonstrate that the Cav3 current decrease is linked to the cumulative Ca^2+^ entry through Cav3 channels. This Ca^2+^-dependent inhibition of Cav3 channels was observed only in the presence of external Ca^2+^ indicating that a voltage-dependent component in the mechanism is unlikely to contribute to the reported effect. Importantly, this Cav3 current inhibition induced by the Ca^2+^ entry is observed using intracellular EGTA but not anymore after the cell dialysis with BAPTA. These data reveal that this Ca^2+^-dependent modulation of Cav3 channels involves a localized increase in submembrane Ca^2+^ at the vicinity of the Cav3 channels without the need for a global Ca^2+^ increase ([@bib47]; [@bib55]; [@bib19]). Interestingly, in the inside-out patch configuration, the direct application of Ca^2+^-containing solutions up to 100 µM to the internal side of the membrane did not produce the current inhibition, suggesting that this phenomenon requires some additional components preserved in the whole-cell configuration.

A key finding of this study is that the current inhibition is closely linked to the resting membrane potential (Vm; see the schematic representation in [Figure 7](#fig7){ref-type="fig"}). On one hand, an increase in submembrane Ca^2+^ promotes a strong negative shift in the steady-state inactivation properties of T-type channels, leading to a more prominent inhibition of the Cav3 current at physiological Vm (\~ −65/--85 mV; [Figure 7](#fig7){ref-type="fig"}). On the other hand, the Ca^2+^ entry via T-type channels is maximal at negative Vm (\~ −100 mV), but the consequence of the shift in the steady-state inactivation is minimized at negative Vm ([Figure 7](#fig7){ref-type="fig"}). Consequently, the inhibition of the Cav3 current is maximal at physiological resting membrane potentials after stimulation at negative HP. Using this paradigm our data revealed an important finding: a wide range of modulation (\~600%) of both Cav3.3 and Cav3.1 currents, but not of Cav3.2 current which was resistant to this modulation.

The lack of Ca^2+^-dependent modulation of Cav3.2 channels using fast TP stimulation protocols could be explained by the specific electrophysiological properties of this Cav3 isoform. It is expected that the Cav3.2 current would generate little cumulative Ca^2+^entry because of its rapid inactivation kinetics combined with its slow recovery from inactivation ([@bib39]; [@bib40]; [@bib56]; [@bib14]; [@bib53]). Interestingly, the Met1549Ile gain-of-function mutant of the Cav3.2 channel that displays very slow inactivation and deactivation kinetics ([@bib57]; [@bib18]), exhibits a significant Ca^2+^-dependent inhibition and a wide range of modulation (\~300%). Collectively, our data indicate that the Ca^2+^-dependent mechanism described here can modulate all three Cav3 isoforms. Overall, the amplitude of the modulation (Cav3.3 \> Cav3.1 \>\> Cav3.2 \~ 0) critically depends on the amount of the Ca^2+^ entry and therefore relies on the biophysical properties of each Cav3 isoform.

The large Ca^2+^ entry generated by the activation of ionotropic receptors induces a strong inhibition (\~85%) of all three Cav3 currents, including wild-type Cav3.2. We observed this effect with a variety of Ca^2+^-permeable ionotropic receptors, including the purinergic P2X4, the glutamatergic NMDA, the serotoninergic 5-HT3 and the TRP (TRPV1 and TRPA1) receptors. Notably, no inhibition of the T-type current is observed when these experiments are performed in the absence of extracellular Ca^2+^, demonstrating the critical role played by the Ca^2+^ entry in this mechanism of Cav3 inhibition. It is noteworthy that the tsA-201 cells, which derived from HEK-293 cells, endogenously express another class of purinergic receptors, P2Y, which are Gq-coupled receptors and induce a global increase in intracellular Ca^2+^ in response to ATP ([@bib13]; [@bib28]). Interestingly, we observed no change Cav3 current properties in pcDNA3 transfected cells ([Figure 6b](#fig6){ref-type="fig"}) indicating that Cav3 currents are not inhibited in P2X untransfected cells following ATP application. These data suggest that activation of P2Y receptors is unable to mediate a Ca^2+^-dependent modulation of Cav3 currents further supporting a membrane-delimited mechanism for the Ca^2+^-dependent modulation of Cav3 channels.

Since the initial discovery of T-type currents, it was admitted that these channels were not regulated by intracellular Ca^2+^ ions or by changes in intracellular Ca^2+^ concentration because they do not present CDI ([@bib11]; [@bib27]; [@bib4]; [@bib9]; [@bib10]; [@bib24]). More recently, these findings were confirmed using cloned T-type channels ([@bib61]; [@bib48]; [@bib53]) but see ([@bib41]). Indeed, our data showing that the inactivation kinetics are similar at the beginning of the stimulation obtained in external Ca^2+^ and in external sodium ([Figure 2e](#fig2){ref-type="fig"}) also support the lack of CDI for Cav3 channels. Accordingly, the important structural motifs for CDI present on L-type channels, as the Ca^2+^ (EF Hand) and the calmodulin (IQ motif) binding sites are absent on the C-terminus of Cav3 channels ([@bib61]; [@bib48]; [@bib53]). Therefore, CDI was considered in pioneer studies as a hallmark to distinguish between L-type and T-type Ca^2+^ currents ([@bib11]; [@bib27]; [@bib4]; [@bib9]; [@bib10]; [@bib24]). Increasing the intracellular Ca^2+^ concentration \[Ca^2+^\]~INT~ from 10^−10^ to 10^−7^ M or even to 10^−6^ M was classically used to isolate a 'pure' T-type current, which presented no change in its inactivation kinetics, whereas the L-type current disappeared because of the acceleration of its 'run-down' ([@bib9]; [@bib10]; [@bib24]). Interestingly, in these seminal studies, the native T-type current was mostly related to Cav3.2 (nickel-sensitive) channels ([@bib11]; [@bib27]; [@bib4]; [@bib9]; [@bib10]; [@bib24]), for which we show that the intrinsic electrophysiological properties do not allow the triggering of the Ca^2+^-dependent current inhibition, contrary to Cav3.1 and Cav3.3 channels. However, and consistent with our present findings, these early studies performed in the presence of an increasing amount of \[Ca^2+^\]~INT~ have reported important features of the T-type current: (1) at 10^−8^ M, the T-type current was stable during 60 min whereas at 10^−7^ M the T-type current decreased and was suppressed after 10--15 min ([@bib9]); (2) at 10^−7^ M, an hyperpolarizing shift (\~10 mV) of the steady-state inactivation occurred ([@bib10]); and (3) at 10^−6^ M no T-type current was recorded at HPs above −100 mV ([@bib24]). Altogether, these historical results and our present data are in favor of a 'minute scale' Ca^2+^-dependent modulation of the T-type current, which induces a hyperpolarizing shift in the steady-state inactivation and consequently a decrease in T-type current amplitude (see [Figure 7](#fig7){ref-type="fig"}).

It is also important to depict our results in the light of recent findings obtained on L-type channels using high frequency of stimulation ([@bib50], [@bib51]). In 15 mM external Ca^2+^, the Cav1.2 current dropped to 40% of the control amplitude during 1 Hz stimulation and this inhibition was abolished in the presence of intracellular BAPTA ([@bib50], [@bib51]). The Cav1.2 current decrease was stable after 3--5 min, similar to that obtained with 40--50 s stimulation for Cav3.3 in the presence of the physiological 2 mM Ca^2+^ concentration, and the recovery was almost total after 4--5 min. However, contrary to Cav3 currents, the decrease in the Cav1.2 current stimulated at 1 Hz did not involve a shift in its steady-state inactivation ([@bib50], [@bib51]), suggesting distinct mechanisms for the L-type and the T-type current modulation. In addition, a prolonged stimulation of Cav1.2 current (in 10 mM external Ca^2+^ saline) induced channel endocytosis ([@bib30]; [@bib63]; [@bib31]) and, in this case, the recovery of the L-type current took approximately 30 min ([@bib30]). This Ca^2+^-dependent modulation of L-type channels appears distinct of that described here for Cav3 channels, both regarding the time of the recovery and the shift in the steady-state inactivation. In addition, we found that ATP treatment in cells expressing both the P2X4 receptors and the Cav3.3 channels did not induce significant changes in membrane expression of Cav3.3, suggesting that the current decrease did not involve an endocytosis mechanism. Therefore, although the L- and the T-type channel regulation share apparent similar properties, modulation of the T-type current by cumulative Ca^2+^ entry has unique features, depending mostly on the shift of the steady-state inactivation, i.e. the modulation of Cav3 availability.

The discovery of a Ca^2+^-driven feedback regulation of T-type channels may have important physiological and pathophysiological implications. Indeed, an increase in the activity of T-type channels have been implicated in several diseases linked to altered Ca^2+^ signaling ([@bib52]; [@bib36]; [@bib57]; [@bib67]; [@bib18]) and T-type channel activity is also linked to Ca^2+^ overload toxicity occurring in ischemia ([@bib49]; [@bib1]; [@bib29]). Also, our study reveals that activation of Ca^2+^-permeable ionotropic receptors could also markedly inhibit T-type channel activity, and interestingly, cross-talk between these receptors and T-type channels have been recently observed ([@bib17]; [@bib38]; [@bib65]; [@bib62]).

In summary, we have identified a novel regulation pathway for T-type Ca^2+^ channels. By demonstrating that Ca^2+^ entry exerts a feedback control on T-type channel activity, our study opens up new horizons towards deciphering how this local and dynamic Ca^2+^-dependent modulation of Cav3 channels can impact the cellular and physiological roles of T-type channels in normal and disease states.

Materials and methods {#s4}
=====================

Cell culture and transfection protocols {#s4-1}
---------------------------------------

tsA-201 cells (RRID:[CVCL_2737](https://scicrunch.org/resolver/CVCL_2737)) were obtained from the European Collection of Authenticated Cell Cultures (ECACC 96121229). The identity of tsA201 has been confirmed by STR profiling and the cells have been eradicated from mycoplasma at ECACC. We routinely tested the cells for the absence of the mycoplasma contamination. Cells were cultivated in DMEM supplemented with GlutaMax, 10% fetal bovine serum and 1% penicillin / streptomycin (Invitrogen, Fisher Scientific, France). Transfections were performed using jet-PEI (Ozyme, France) with a DNA mix (1.5 µg total) containing 0.5% of a GFP encoding plasmid and 99.5% of either of the plasmids (pcDNA3.1) that code for the human Cav3.1a, Cav3.2, Cav3.3 and Met1549Ile Cav3.2 constructs. In experiments with ionotropic receptors, 1 µg of either of the plasmid constructs that code for human P2X4, mouse 5-HT3, human TRPV1, mouse TRPA1 and rat NMDA receptor (NR1A and NR2A (0.5 µg each)) were added to the DNA mix. Two days after transfection, tsA-201 cells were dissociated with Versene (Invitrogen, Fisher Scientific, France) and plated at a density of \~35 × 10^3^ cells per 35 mm Petri dish for electrophysiological recordings, which were performed the following day.

DRG neurons {#s4-2}
-----------

All animal use procedures were done in accordance with the directives of the French Ministry of Agriculture (A 34-172-41). Dorsal root ganglion (DRG) neurons were prepared as described earlier ([@bib64]). Briefly, adult male C57BL/6J mice were anaesthetized with pentobarbital injection and transcardially perfused with HBSS (pH 7.4, 4°C). Lumbar DRGs with attached roots were dissected and collected in cold HBSS supplemented with 5 mM HEPES, 10 mM D-glucose and 1% penicillin/streptomycin. DRGs were treated with 2 mg/ml collagenase II and 5 mg/ml dispase for 40 min at 37°C, washed in HBSS and resuspended in 1 ml of neurobasal A medium supplemented with B27, 2 mM L-glutamine and 1% penicillin/streptomycin (Invitrogen, Fisher Scientific, France). Single-cell suspensions were obtained by 5 passages through three needle tips of decreasing diameter (gauge 18, 21, and 26). Cells were plated onto polyornithine/laminin-coated dishes. After 2 hr, the medium was removed and replaced with neurobasal B27 supplemented with 10 ng/ml neurotrophin 4 (NT4) and 2 ng/ml glial derived neurotrophic factor (GDNF). Patch clamp recordings were performed 6--24 hr after plating on neurons with a 'rosette' morphology corresponding to D-hair neurons that express alarge density of T-type current ([@bib23]; [@bib64]).

Electrophysiological recordings {#s4-3}
-------------------------------

Macroscopic currents were recorded at room temperature using an Axopatch 200B amplifier (Molecular Devices, Sunnyvale CA). Borosilicate glass pipettes had a resistance of 1.5--2.5 MOhm when filled with an internal solution containing (in mM): 140 CsCl, 10 EGTA, 10 HEPES, 3 Mg-ATP, 0.6 GTPNa, and 3 CaCl~2~ (pH adjusted to 7.25 with KOH, \~315 mOsm, \~100 nM free Ca^2+^ using the MaxChelator software, <http://maxchelator.stanford.edu/>). Similar results were obtained using either 10 mM or 20 mM EGTA. In some experiments, BAPTA (20 mM) was substituted with EGTA. The extracellular solution contained (in mM): 135 NaCl, 20 TEACl, 2 CaCl~2~, 1 MgCl~2~, and 10 HEPES (pH adjusted to 7.25 with KOH, \~330 mOsm). To avoid inhibition of 5-HT3 and NMDA receptors, NaCl was substituted with TEACl and MgCl~2~ was also omitted in NMDA experiments. In the cell-free inside-out patch experiments the intrapipette solution contained 100 mM BaCl~2~ and 10 mM HEPES (pH adjusted to 7.25 with NaOH, \~310 mOsm) and the bath solution contained (in mM): 145 KCl, 10 HEPES and 1 MgCl~2~ (pH adjusted to 7.25 with KOH, \~305 mOsm). In the inside-out configuration the patch was perfused with the bath solution supplemented with either 1 mM EGTA or increasing the concentration of CaCl~2~ (1, 10 and 100 µM). For D-hair neuron recordings, the bath solution contained (in mM): 140 NaCl, 10 HEPES, 5 KCl, 2 CaCl~2~, 1 MgCl~2~ and 10 glucose (pH adjusted to 7.25 with NaOH, \~330 mOsm) and cells were perfused with an extracellular solution containing (in mM): 140 TEACl, 10 HEPES, 5 KCl, 2 NaCl, 2 CaCl~2~, 1 MgCl~2~ and 10 glucose (pH adjusted to 7.25 with TEAOH, \~330 mOsm). Recordings were filtered at 2 kHz. Steady-state inactivation curves were fitted using the Boltzmann equation where I/I max = 1/(1+exp((Vm−V~0.5~)/slope factor)). Data were analyzed using pCLAMP9 (Molecular Devices) and GraphPad Prism (GraphPad) softwares. Results are presented as the mean ± SEM, and n is the number of cells. Statistical analysis was performed with the Student *t*-test or with one-way ANOVA combined with a Tukey post-test for multiple comparisons (\*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001).

Modelling {#s4-4}
---------

Modelling was performed using the NEURON simulation environment ([@bib32]). The model was modified to simulate voltage-clamp experiments in thalamic reticular neurons ([@bib20]) (as available from the model database at Yale University (<https://senselab.med.yale.edu/modeldb/>). The electrophysiological properties of the Cav3.3 channels were modelled using Hodgkin-Huxley equations as described previously ([@bib33]; [@bib20]). The values obtained for Cav3.3 were substituted for the corresponding values of native T-channels in thalamic reticular neurons ([@bib33]), as previously described ([@bib14]). To match the voltage clamp data, the modelling experiments were performed at 24°C.

The equations to model the Cav3.3 current properties at rest were:$$\begin{matrix}
{m\infty} & {= 1/\left( {1 + exp\left( {- \left( {v + 52.6} \right)/4.7} \right)} \right)} \\
{h\infty} & {= 1/\left( {1 + exp\left( {\left( {v + 72.4} \right)/5.7} \right)} \right)} \\
{tau_{m}} & {= \left( {1.377 + 1.512/\left( {exp\left( {\left( {v + 12.52} \right)/14.38} \right) + exp\left( {- \left( {v + 81.59} \right)/5} \right)} \right)} \right)} \\
{tau_{h}} & {= \left( {65.34 + 1/\left( {exp\left( {\left( {v + 41.04} \right)/4.01} \right) + exp\left( {- \left( {v + 333.1} \right)/46.86} \right)} \right)} \right)} \\
\end{matrix}$$

The equations to model the Cav3.3 current properties after 40 s stimulation at 1 Hz frequency were:$$\begin{matrix}
{m\infty} & {= 1/\left( {1 + exp\left( {- \left( {v + 55.9} \right)/5.6} \right)} \right)} \\
{h\infty} & {= 1/\left( {1 + exp\left( {\left( {v + 81.1} \right)/5} \right)} \right)} \\
{tau_{m}} & {= \left( {1.141 + 0.9592/\left( {exp\left( {\left( {v + 14.95} \right)/13.97} \right) + exp\left( {- \left( {v + 81.53} \right)/5} \right)} \right)} \right)} \\
{tau_{h}} & {= \left( {26.55 + 0.66/\left( {exp\left( {\left( {v + 32.42} \right)/6.4} \right) + exp\left( {- \left( {v + 225} \right)/22.21} \right)} \right)} \right)} \\
\end{matrix}$$

Luminometric analysis of HA-tagged Cav3.3 channels {#s4-5}
--------------------------------------------------

The membrane expression of the Cav3.3 channel was quantified as previously described ([@bib16]). The tsA-201 cells were cultured in 24-well plates and co-transfected with a Cav3.3-HA construct ([@bib3]) and either the P2X4 receptor or the pcDNA3 plasmid (ratio 1:1). Two days after transfection, ATP treatments were performed as in the electrophysiological experiments. The cells were washed with the electrophysiological extracellular solution containing 3 µM ivermectin and afterward 10 µM ATP was applied for 30--45 s at room temperature. Then the cells were directly fixed for 5 min in PBS containing 4% paraformaldehyde. After three PBS washes, the cells were incubated for 30 min in blocking solution (PBS plus 1% fetal bovine serum). The Cav3.3-HA protein was detected using a rat anti-HA monoclonal antibody (1:1000 dilution; clone 3F10, Roche Diagnostics, France) after incubation for 1 hr at room temperature. After four washes with PBS plus 1% fetal bovine serum for 10 min, cells were incubated for 30 min with horseradish peroxidase-conjugated goat anti-rat secondary antibody (1:1000 dilution; Jackson ImmunoResearch Laboratories, West Grove, PA). Cells were rinsed four times with PBS for 10 min before addition of SuperSignal enzyme-linked immunosorbent assay Femto maximum sensitivity substrate (Pierce, Fisher Scientific, France). Luminescence was measured using a VICTOR2 luminometer (PerkinElmer Life Sciences, Waltham, MA), and the protein amount in each well was then measured using the BCA assay (Pierce, Fisher Scientific, France) to normalize the measurements. All data were normalized to the level of signal obtained in P2X4 transfected cells without the ATP treatment. Each experiment was performed in quadruplicate and three independent sets of transfection experiments were performed under each condition. The results are presented as the mean ± SEM.

Chemical reagents {#s4-6}
-----------------

Compounds were purchased from Sigma (France). To activate ionotropic receptors, we used 10 µM ATP in the presence of 3 µM ivermectin for P2X4, 100 µM glutamate in the presence of 100 µM glycine for NMDA, 10 µM serotonin for 5-HT3, 0.5 µM capsaicin for TRPV1 and 100 µM allyl isothiocyanate for TRPA1. Drugs were applied using a gravity-driven homemade perfusion device and control experiments were performed similarly using the vehicle alone.
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Thank you for submitting your article \"Activity-dependent regulation of T-type calcium channels by submembrane calcium ions\" for consideration by *eLife*. Your article has been favorably evaluated by Richard Aldrich as the Senior Editor and three reviewers, one of whom, Baron Chanda (Reviewer \#1), is a member of our Board of Reviewing Editors. The following individual involved in review of your submission has agreed to reveal their identity: Henry M. Colecraft (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. We hope you will be able to submit the revised version within two months.

Summary:

The reviewers agree that this is an interesting study that convincingly establishes that calcium ions are able to alter the function of native and transiently expressed T-type calcium channels. They show that calcium entry via the channel itself is able to induce this type of feedback inhibition, similar to what has been observed in Cav1.x and Cav2.x channels. The notion that intracellular calcium regulates T-type channels is not accepted or highlighted in the T-type literature. The T-type channels also lack the Ca^2+^ and calmodulin binding motifs found in L-type channels. In that context, this work is important because it provides the clearest evidence to date of Ca^2+^ regulation of distinct T-type channel isoforms in a manner that could potentially be physiologically important. The study also highlights the conserved nature of calcium regulation in voltage-gated calcium channels.

Essential Revisions:

Despite overall enthusiasm about this study, there were number of concerns that should be addressed in the revised version.

1\) The magnitude of the inhibition of T-type current seen (\> 80%) in [Figures 1 and 6](#fig6){ref-type="fig"} appear much larger than can be accounted for by the sole mechanism proposed by the authors; i.e. a 5-10 mV hyperpolarizing shift in the steady-state inactivation curves. It is possible there is also a rightward shift in the voltage-dependence of the activation curve that contributes to the apparent inhibition seen. The authors should determine whether the activation curve is shifted under one of the conditions in which the steady-state inactivation is left-shifted.

Alternatively, this can be addressed by building quantitative models to show whether calcium dependent shifts in inactivation can account for this inhibition.

2\) The electrophysiological pulse protocols used to elicit Ca^2+^-dependent inhibition of the currents are fairly non-physiological. This is fine for probing the phenomenon and the underlying biophysical mechanisms. Nevertheless, the authors speculate about the physiological implications of their results. The impact of the study would be enhanced if the phenomenon could be demonstrated (perhaps in Cav3.3 where the effect is most robust) with more physiological activation paradigms such as action potential waveforms. Alternatively, I think what would be more compelling is to show that under physiological conditions (i.e., in neurons), native calcium permeable receptors are able to modulate native T-type currents, and by extension, affect neuronal output.

3\) A previous study (Lacinova et al., 2006, not cited by the authors) has reported calcium dependent effects on Cav3.1 channel gating that are opposite to those reported here and a similar calcium dependent slowing of inactivation kinetics of Cav3.1 was reported by Monteil et al., 2000 (see [Figure 6C](#fig6){ref-type="fig"} in that study). This should be discussed and discrepancies to the present work explained.

4\) Please discuss how big is the shift in half inactivation voltage after ionomycin treatment -- i.e., is it greater than what is observed upon repetitive stimulation?

5\) We realize that the trying to figure out the molecular mechanism of modulation is not within the scope of this manuscript, we would like to suggest that the authors add some simple experiments that would shed light on the mechanism. For instance, is this inhibition observed in inside out patches. Because if it is not a direct effect and requires accessory proteins, one would expect that this inhibition will not be observed. We believe that this should be a straightforward and insightful experiment.

10.7554/eLife.22331.016

Author response

*Essential Revisions:*

*Despite overall enthusiasm about this study, there were number of concerns that should be addressed in the revised version.*

1\) The magnitude of the inhibition of T-type current seen (\> 80%) in [Figures 1 and 6](#fig6){ref-type="fig"} appear much larger than can be accounted for by the sole mechanism proposed by the authors; i.e. a 5-10 mV hyperpolarizing shift in the steady-state inactivation curves. It is possible there is also a rightward shift in the voltage-dependence of the activation curve that contributes to the apparent inhibition seen. The authors should determine whether the activation curve is shifted under one of the conditions in which the steady-state inactivation is left-shifted.

*Alternatively, this can be addressed by building quantitative models to show whether calcium dependent shifts in inactivation can account for this inhibition.*

We agree that in the previous version of the manuscript, we have not addressed the possibility that a shift in the voltage-dependence of the activation curve may contribute to the apparent inhibition seen. Therefore, we have performed new experiments to address this point. As the calcium-dependent current inhibition is a very dynamic process in both its induction and recovery (T~0.5~ \~ 20s) we have used a pair-pulse protocol, as presented in new version of the [Figure 3](#fig3){ref-type="fig"}. We found that the calcium-dependent inhibition is associated with a slight leftward shift (\~3 mV) in the steady-state activation curve of Cav3.3 but not with a rightward shift ([Figure 3E-F](#fig3){ref-type="fig"} and subsection "Ca^2+^ entry during fast TP stimulation induces a negative shift in the steady-state inactivation", first paragraph). This leftward shift in the steady-state activation is not expected to induce Cav3.3 current inhibition. In addition, we have found no significant variation in the steady-state activation curve of Cav3.1, for which the steady-state inactivation curve is significantly shifted to the left ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"} and the last paragraph of the aforementioned subsection).

We have also performed a simulation of Cav3.3 properties before and after the calcium-dependent current inhibition using the NEURON simulation environment ([Figure 4A](#fig4){ref-type="fig"} and described in Methods, subsection "Modelling"). This simulation predicts that the calcium-dependent current inhibition would induce \~75% inhibition of the Cav3.3 current recorded from a holding potential of -70 mV ([Figure 4A](#fig4){ref-type="fig"} and subsection "Ca^2+^-dependent inhibition of T-type channels is higher at physiological resting membrane potentials", first paragraph). It is important to note that this value corresponds well with those obtained during the experiments presented in [Figure 5](#fig5){ref-type="fig"} obtained at 1 Hz frequency of stimulation.

In addition, the magnitude of the shift in the steady-state inactivation curve is higher after ionomycin treatment \~22 mV ([Figure 1](#fig1){ref-type="fig"}, see the major point 4) and after P2X4 activation (\~16 mV, new [Figure 7](#fig7){ref-type="fig"}), which could explain the strong inhibition of the Cav3 current at physiological resting membrane potentials.

*2) The electrophysiological pulse protocols used to elicit Ca^2+^-dependent inhibition of the currents are fairly non-physiological. This is fine for probing the phenomenon and the underlying biophysical mechanisms. Nevertheless, the authors speculate about the physiological implications of their results. The impact of the study would be enhanced if the phenomenon could be demonstrated (perhaps in Cav3.3 where the effect is most robust) with more physiological activation paradigms such as action potential waveforms. Alternatively, I think what would be more compelling is to show that under physiological conditions (i.e., in neurons), native calcium permeable receptors are able to modulate native T-type currents, and by extension, affect neuronal output.*

We completely agree with this point and we have performed new experiments with Cav3.3 using action potential waveforms (new [Figure 6](#fig6){ref-type="fig"}). We used typical thalamic neuronal activities that we have previously used to characterize difference in behavior among Cav3 isoforms (Chemin et al., 2002 "Specific contribution of human T-type calcium channel isotypes (a1G, a1H and a1I) to neuronal excitability"). We have found that the Cav3.3 current strongly decreases during this neuronal activity (new [Figure 6](#fig6){ref-type="fig"}, subsection "Ca^2+^-dependent inhibition of Cav3.3 current during action potential (AP) clamp stimulation."). In average the Cav3.3 current decrease was \~50% for the first stimulation, which lasted only 500 ms ([Figure 6C](#fig6){ref-type="fig"}) and increases to \~ 80% at the 20^th^ stimulation ([Figure 6D](#fig6){ref-type="fig"}). Importantly, no such decrease in Cav3.3 current was observed in cells dialyzed with BAPTA ([Figure 6B-D](#fig6){ref-type="fig"}). We thank the reviewers for their suggestion, which greatly enhance the impact of our study.

*3) A previous study (Lacinova et al., 2006, not cited by the authors) has reported calcium dependent effects on Cav3.1 channel gating that are opposite to those reported here and a similar calcium dependent slowing of inactivation kinetics of Cav3.1 was reported by Monteil et al., 2000 (see [Figure 6C](#fig6){ref-type="fig"} in that study). This should be discussed and discrepancies to the present work explained.*

In the [Figure 6C](#fig6){ref-type="fig"} of our precedent article "Monteil et al., 2000", the Cav3.1 (named α1G at this time) current was recorded at low frequencies of stimulation (0.2 Hz or 0.1 Hz) and the permeation properties of the Cav3.1 channel was tested with calcium, barium and strontium. It should be noted that at these low frequencies calcium does not induce Cav3.1 current inhibition ([Figure 2G](#fig2){ref-type="fig"} in our present article) and accordingly no inhibitory effect of calcium was found in Monteil et al., 2000. In addition, the effect of barium or strontium at low frequency of stimulation mainly depends of the Cav3 isoform used and is expected to depend on difference in residues present in (or surrounding) the P-loop of the channels (for example see McRory et al., 2001 "Molecular and functional characterization of a family of rat brain T-type calcium channels."). Importantly, we have not described in our present study the effect of barium ions ([Figure 6C](#fig6){ref-type="fig"} in Monteil et al., 2000) but instead we have used intracellular BAPTA (as compared to EGTA) to probe calcium-dependent effect. Therefore, we believe that there is no discrepancy between our present results and those reported by Monteil et al., 2000.

In the study of Lacinova et al., 2006 (cited in the sixth paragraph of the Discussion), the Cav3.1 current was compared between different extracellular and intracellular solution. The authors mainly compare 2 extreme conditions: "high intracellular calcium concentration" which was 20 mM external calcium combined with 200 µM free internal calcium; and "0 divalent cation" which was 135 mM external sodium combined with 4 mM intracellular EGTA. Although this study presents interesting results it is very difficult to compare these results with our study (physiological external 2 mM calcium and an internal medium containing EGTA combined with calcium to match physiological concentration at rest \~100 nM) for the following reasons. First, as directly mentioned by the authors (p252), "non-specific voltage shifts due to altered surface charge took place" when comparing both conditions and therefore a shift in the steady-state inactivation (or activation) could not be quantitatively compared (as discussed p254 and p 256). Therefore, the rightward shift in the inactivation curve observed with the "high intracellular calcium concentration" was completely expected by a screen charge effect (20 mM external calcium versus 0 external divalent). Second, the dialysis of the cell for several minutes in 4 mM EGTA/0 Ca or in 200 µM Ca/ 0 EGTA may lead to major change in the cell metabolism, as the prolonged activation/inhibition of several calcium-dependent enzymes (that possibly may lead to Cav3 channel modulation), which was not the case in our study mainly comparing the effect of internal EGTA and BAPTA. However, we do not think that this study reported opposite results as compared to our study. Again, it is important to note that experiments in Lacinova et al., were performed at the frequency of stimulation of 0.2 Hz (p252), a frequency for which we found no calcium-dependent inhibition for Cav3.1 current (and therefore no shift in the steady-state inactivation, as observed in [Figure 3A](#fig3){ref-type="fig"} in Lacinova et al.). In addition, using "intermediate" solutions (that limit altered surface charge change), the authors showed that the Cav3.1 current is increased in the presence of intracellular EGTA as compared to 200 µM intracellular calcium (both in 20 mM external calcium). The same results were observed when comparing the 135 mM external sodium and the 2 mM external calcium (both with EGTA in the intracellular calcium). This suggests that an increase in intracellular calcium promotes the current inhibition ([Figure 2A](#fig2){ref-type="fig"} in Lacinova et al.). Also, in the presence of 20 mM external calcium, the inactivation kinetics (and -- to a lesser extent -- the activation kinetics) of the Cav3.1 current were faster in the presence of internal calcium as compared to internal EGTA ([Figure 2D and E](#fig2){ref-type="fig"} in Lacinova et al.). Overall, although it is very difficult to directly compare our results with those of Lacinova et al. (especially concerning the inactivation curves), we do believe that our study provides data that are not opposite or incompatible with those of Lacinova et al. (2006).

*4) Please discuss how big is the shift in half inactivation voltage after ionomycin treatment -- i.e., is it greater than what is observed upon repetitive stimulation?*

We now report the voltage shift in the inactivation curve after ionomycin treatment in the new version of [Figure 1](#fig1){ref-type="fig"}. We found in sensory neurons that ionomycin induced \~22 mV shift in the half inactivation voltage of the native T-current ([Figure 1C](#fig1){ref-type="fig"} and subsection "Inhibition of the native T-type and the recombinant Cav3 currents by ionomycin"). Similarly, the ionomycin treatment induced \~23 mV leftward shift in the steady-state activation of recombinant Cav3.1, Cav3.2 and Cav3.3. This shift is 2 fold bigger than those observed upon repetitive stimulation (\~10 mV, Figure 3dD and subsection "Ca^2+^ entry during fast TP stimulation induces a negative shift in the steady-state inactivation", first paragraph) and could account for the strong inhibitory effect of ionomycin at physiological resting membrane potential (see major point 1).

*5) We realize that the trying to figure out the molecular mechanism of modulation is not within the scope of this manuscript, we would like to suggest that the authors add some simple experiments that would shed light on the mechanism. For instance, is this inhibition observed in inside out patches. Because if it is not a direct effect and requires accessory proteins, one would expect that this inhibition will not be observed. We believe that this should be a straightforward and insightful experiment.*

As proposed by the reviewers, we have performed inside-out experiments with Cav3.3 (new [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). We have recorded the Cav3.3 current in the presence of 100 mM barium in the patch-pipette (in order to record significant Cav3.3 current and not to produce the possible calcium-dependent inhibition due to the permeation of external calcium, as observed in whole-cell experiments) and we have stimulated the channels with voltage-ramps applied at a frequency of 0.2 Hz ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). It is important to note that the used of external 100 mM divalent concentration induces a strong positive shift in V0.5 values due to altered surface charge (as compared to physiological 2 mM calcium, see point 3). Indeed, in the inside-out configuration, we found that at a holding potential (HP) of -50 mV, only the half of channels are inactivated (\~47% ). Therefore, as the calcium effect observed in the whole-cell configuration is more robust at depolarized HPs (-70 / -80 mV), we used HP -50 mV in the inside-out configuration to match whole-cell experiments and possibly maximize the putative direct effect of calcium. Before patch excision, the cells were perfused with a solution containing 1 mM EGTA / 0 Ca and the inside-out patch configuration was performed ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). Afterward, the effect on the Cav3.3 current of calcium containing solutions (1, 10 and 100 µM) were tested and compared to the 1 mM EGTA / 0 Ca solution ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). In average we found no significant effect of these calcium solutions ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}, subsection "Inhibition of Cav3.3 current at high frequency of stimulation is caused by the Ca^2+^ entry", third paragraph) suggesting that intracellular calcium does not directly affect the Cav3.3 current. Higher concentration of calcium (mM) could not be investigated because we observed a strong tendency of the patches to form vesicles, which were very resistant to air and most of the time irreversible.
